Last reviewed · How we verify
NCT06001918: stAAAble
Nectero EAST System Clinical Study
Phase 2, PHASE3 trial testing Nectero EAST System in Abdominal Aortic Aneurysm in 400 participants. Currently enrolling.
31 March 2028
Quick facts
| Lead sponsor | Nectero Medical, Inc. |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 400 |
| Start date | 25 October 2023 |
| Primary completion | 31 March 2028 |
| Estimated completion | 31 December 2029 |
| Sites | 39 locations across New Zealand, United States, Australia |
Drugs / interventions tested
- Nectero EAST System — full drug profile →
Conditions studied
- Abdominal Aortic Aneurysm — all drugs for Abdominal Aortic Aneurysm →
Sponsor
Nectero Medical, Inc. — full company profile →
Who can join
Adults 21 to 85, any sex, with Abdominal Aortic Aneurysm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06001918
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Abdominal Aortic Aneurysm
Currently open trials in the same condition.
- NCT07476196 — Poland-Italy Aortic Research Bridge Real World Registry · recruiting
- NCT07473102 — PET Imaging of MMP Activation in AAA: Clinical Component · EARLY_PHASE1 · recruiting
- NCT06451315 — REGISTRY on the Implementation of Artificial Intelligence in the Automatic Analysis of Vascular Network Segmentation · recruiting
- NCT06008613 — 3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair · NA · active not recruiting
- NCT05617326 — Screening for Abdominal Aortic Aneurysms in the General Practice by Ultraportable Ultrasound · NA · recruiting
Other Nectero Medical, Inc. trials
Trials by the same sponsor.
- NCT05133492 — First In Human Study for Small to Medium-sized Abdominal Aortic Aneurysm (AAA) · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06001918 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nectero Medical, Inc.
- Last refreshed: 30 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06001918.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing